ES318143A1 - Un procedimiento para la produccion de compuestos de dioxi-do de perhidro-1,2,4-tiadiazina. - Google Patents
Un procedimiento para la produccion de compuestos de dioxi-do de perhidro-1,2,4-tiadiazina.Info
- Publication number
- ES318143A1 ES318143A1 ES318143A ES318143A ES318143A1 ES 318143 A1 ES318143 A1 ES 318143A1 ES 318143 A ES318143 A ES 318143A ES 318143 A ES318143 A ES 318143A ES 318143 A1 ES318143 A1 ES 318143A1
- Authority
- ES
- Spain
- Prior art keywords
- ring
- group
- dioxide
- perhydrothiadiazine
- taurine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 abstract 6
- 239000002253 acid Substances 0.000 abstract 4
- 125000001570 methylene group Chemical group [H]C([H])([*:1])[*:2] 0.000 abstract 4
- XOAAWQZATWQOTB-UHFFFAOYSA-N Taurine Natural products NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 abstract 3
- 125000000217 alkyl group Chemical group 0.000 abstract 3
- 150000001875 compounds Chemical class 0.000 abstract 3
- 150000003839 salts Chemical class 0.000 abstract 3
- KISXBSWDCSYUKO-UHFFFAOYSA-N thiadiazinane 1,1-dioxide Chemical class O=S1(=O)CCCNN1 KISXBSWDCSYUKO-UHFFFAOYSA-N 0.000 abstract 3
- RJGYJMFQWGPBGM-UHFFFAOYSA-N 1,2,4-thiadiazinane 1,1-dioxide Chemical class O=S1(=O)CCNCN1 RJGYJMFQWGPBGM-UHFFFAOYSA-N 0.000 abstract 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 abstract 2
- 125000003710 aryl alkyl group Chemical group 0.000 abstract 2
- 125000004432 carbon atom Chemical group C* 0.000 abstract 2
- 125000000753 cycloalkyl group Chemical group 0.000 abstract 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 2
- -1 linctuses Substances 0.000 abstract 2
- 125000004433 nitrogen atom Chemical group N* 0.000 abstract 2
- 229960003080 taurine Drugs 0.000 abstract 2
- MVQXBXLDXSQURK-UHFFFAOYSA-N 2-aminoethanesulfonamide Chemical compound NCCS(N)(=O)=O MVQXBXLDXSQURK-UHFFFAOYSA-N 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- 239000000443 aerosol Substances 0.000 abstract 1
- 229910021529 ammonia Inorganic materials 0.000 abstract 1
- 230000000844 anti-bacterial effect Effects 0.000 abstract 1
- 125000003118 aryl group Chemical group 0.000 abstract 1
- 239000002775 capsule Substances 0.000 abstract 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 abstract 1
- 239000003054 catalyst Substances 0.000 abstract 1
- 238000009903 catalytic hydrogenation reaction Methods 0.000 abstract 1
- 238000006243 chemical reaction Methods 0.000 abstract 1
- 125000004663 dialkyl amino group Chemical group 0.000 abstract 1
- 239000008298 dragée Substances 0.000 abstract 1
- 230000000855 fungicidal effect Effects 0.000 abstract 1
- 150000004820 halides Chemical class 0.000 abstract 1
- 229910052736 halogen Inorganic materials 0.000 abstract 1
- 150000002367 halogens Chemical class 0.000 abstract 1
- 238000002347 injection Methods 0.000 abstract 1
- 239000007924 injection Substances 0.000 abstract 1
- 239000006210 lotion Substances 0.000 abstract 1
- 239000007937 lozenge Substances 0.000 abstract 1
- 229910052757 nitrogen Inorganic materials 0.000 abstract 1
- 239000002674 ointment Substances 0.000 abstract 1
- MUMZUERVLWJKNR-UHFFFAOYSA-N oxoplatinum Chemical compound [Pt]=O MUMZUERVLWJKNR-UHFFFAOYSA-N 0.000 abstract 1
- 239000006072 paste Substances 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 125000005544 phthalimido group Chemical group 0.000 abstract 1
- 125000001557 phthalyl group Chemical group C(=O)(O)C1=C(C(=O)*)C=CC=C1 0.000 abstract 1
- 229910003446 platinum oxide Inorganic materials 0.000 abstract 1
- 150000003140 primary amides Chemical class 0.000 abstract 1
- 150000003141 primary amines Chemical class 0.000 abstract 1
- 238000006798 ring closing metathesis reaction Methods 0.000 abstract 1
- 239000000243 solution Substances 0.000 abstract 1
- 239000007921 spray Substances 0.000 abstract 1
- 239000000126 substance Substances 0.000 abstract 1
- 125000001424 substituent group Chemical group 0.000 abstract 1
- 239000000829 suppository Substances 0.000 abstract 1
- 235000020357 syrup Nutrition 0.000 abstract 1
- 239000006188 syrup Substances 0.000 abstract 1
- 239000003826 tablet Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
- C07D285/15—Six-membered rings
- C07D285/16—Thiadiazines; Hydrogenated thiadiazines
- C07D285/18—1,2,4-Thiadiazines; Hydrogenated 1,2,4-thiadiazines
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB40734/64A GB1124285A (en) | 1964-10-06 | 1964-10-06 | Novel perhydro-1,2,4-thiadiazine dioxides-(1,1), their preparation and compositionscontaining them |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES318143A1 true ES318143A1 (es) | 1968-03-16 |
Family
ID=10416354
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES318143A Expired ES318143A1 (es) | 1964-10-06 | 1965-10-05 | Un procedimiento para la produccion de compuestos de dioxi-do de perhidro-1,2,4-tiadiazina. |
Country Status (6)
Families Citing this family (32)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CH600878A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) * | 1975-04-28 | 1978-06-30 | Gaba Ag | |
| GB1557163A (en) * | 1975-06-24 | 1979-12-05 | Geistlich Soehne Ag | Dental care preparations |
| US4337251A (en) * | 1979-05-09 | 1982-06-29 | Ed. Geistlich Sohne Ag Fur Chemische Industrie | Method of avoiding and removing adhesions |
| GB8328073D0 (en) * | 1983-10-20 | 1983-11-23 | Geistlich Soehne Ag | Chemical compounds |
| DE19515976C1 (de) * | 1995-05-02 | 1996-10-10 | Claus Prof Dr Herdeis | beta-Azidoethansulfonylazid, Verfahren zu seiner Herstellung und seine Verwendung in Verfahren zur Herstellung von Taurinamid und Taurolidin |
| GB9626795D0 (en) | 1996-12-23 | 1997-02-12 | Geistlich Soehne Ag | Combating infection in delivery systems |
| DE19708782C1 (de) * | 1997-03-04 | 1998-08-06 | Claus Prof Dr Herdeis | Verfahren zur Herstellung von 2-Aminoethansulfonylazid-säureadditionssalzen, 2-Aminoethansulfonylazid-hydrochlorid sowie dessen Verwendung |
| US6011030A (en) * | 1997-09-22 | 2000-01-04 | Ed. Geistlich Sohne Ag Fur Chemische Industrie | Method of treating symptoms of microbial infection or sepsis |
| FR2771928B1 (fr) * | 1997-12-05 | 2001-04-13 | Jean Noel Thorel | Composition comprenant des derives de taurine ; son utilisation comme agent conservateur d'un produit alimentaire, ou pharmaceutique, topique ou cosmetique |
| US5972933A (en) * | 1998-01-08 | 1999-10-26 | Ed. Geistlich Sohne Ag Fur Chemische Industrie | Method of treating microbial infections |
| US6166007A (en) | 1998-07-02 | 2000-12-26 | Sodemann; Klaus | Antimicrobial locks comprising taurinamide derivatives and carboxylic acids and/or salts thereof |
| US6350742B1 (en) * | 1998-09-11 | 2002-02-26 | Carter-Wallace, Inc. | Compositions and methods for treating infections of the ear |
| US6117868A (en) * | 1998-09-16 | 2000-09-12 | Ed. Geistlich Sohne Ag Fur Chemische Industrie | Treatment of gastrointestinal ulcers or gastritis caused by microbial infection |
| KR20010016065A (ko) * | 1999-11-29 | 2001-03-05 | 울프 크라스텐센, 스트라쎄 로텐베르그 | 1,1-디옥소퍼히드로-1,2,4-티아디아진의 용도 |
| ES2438535T3 (es) | 1999-12-06 | 2014-01-17 | Geistlich Pharma Ag | Taurolidina o taurultamo para uso en el tratamiento de tumores de próstata, de colon, de pulmón y para el tratamiento del glioblastoma multiforme recurrente |
| CN100519525C (zh) * | 1999-12-06 | 2009-07-29 | 葛兰素集团有限公司 | 芳香砜类及其医疗用途 |
| US20020004502A1 (en) * | 2000-01-05 | 2002-01-10 | Redmond H. Paul | Treatment of inflammatory bowel disease |
| CA2462564C (en) | 2001-10-01 | 2012-07-10 | Rhode Island Hospital | Methods of inhibiting metastases |
| CN1301110C (zh) * | 2002-04-01 | 2007-02-21 | Nd合伙人股份有限公司 | 包含牛磺酰胺衍生物及羧酸和/或其盐的抗微生物闭锁 |
| ATE354380T1 (de) * | 2003-02-03 | 2007-03-15 | Polaschegg Hans-Dietrich Dr Te | Zusammensetzung zur prävention von infektionen durch subkutane prothesen |
| US20050008684A1 (en) * | 2003-07-10 | 2005-01-13 | Claus Herdeis | Method of treatment for acne, rosacea and ulcers with taurolidine and/or taurultam in a pharmaceutical composition |
| EP1647276A1 (en) * | 2004-10-14 | 2006-04-19 | Boehringer Ingelheim Vetmedica Gmbh | Use of taurolidine formulations for the intramammary treatment of mastitis |
| US7696182B2 (en) | 2004-11-02 | 2010-04-13 | Nd Partners, Llc | Antimicrobial locking solutions comprising taurinamide derivatives and biologically acceptable salts and acids, with the addition of small concentrations of heparin |
| ES2318628T3 (es) | 2006-07-25 | 2009-05-01 | Claus Herdeis | Preparacion de formulaciones antimicrobianas que comprenden 7-oxa-2-tia-1,5 diazabiciclo(3.3.1)-nonan-2,2-diona. |
| DE102010010360A1 (de) * | 2010-03-05 | 2011-09-08 | Gamptec Gmbh | Formulierungen von Taurolidin und Verfahren zu seiner Herstellung |
| CA2812845A1 (en) | 2010-09-27 | 2012-04-05 | Geistlich Pharma Ag | Antimicrobial dental care preparation |
| WO2012070066A1 (en) | 2010-11-23 | 2012-05-31 | Biophore India Pharmaceuticals Pvt. Ltd. | Process for the preparation of taurolidine and its intermediates thereof |
| EP2908824B1 (en) | 2012-10-17 | 2018-05-02 | Merck Sharp & Dohme Corp. | Tricyclic substituted thiadiazine dioxide compounds as bace inhibitors, compositions, and their use |
| US9422277B2 (en) | 2012-10-17 | 2016-08-23 | Merck Sharp & Dohme Corp. | Tricyclic substituted thiadiazine dioxide compounds as BACE inhibitors, compositions and their use |
| PT3233813T (pt) * | 2014-12-19 | 2022-03-14 | Geistlich Pharma Ag | Processos para preparação de compostos de tipo oxatiazina |
| CA3086396A1 (en) | 2017-12-21 | 2019-06-27 | Cormedix Inc. | Methods and pharmaceutical compositions for treating candida auris in blood |
| US11738120B1 (en) | 2022-04-14 | 2023-08-29 | Cormedix Inc. | Synthesis of taurolidine, purity profiles and polymorphs |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3103511A (en) * | 1963-09-10 | Derivatives of | ||
| US2466396A (en) * | 1947-11-22 | 1949-04-05 | Eastman Kodak Co | 6-membered heterocyclic compounds |
| US3108124A (en) * | 1961-07-28 | 1963-10-22 | Abbott Lab | Method for manufacture of 5-chloro-2, 4-bis (methylsulfamyl)-aniline |
-
1964
- 1964-10-06 GB GB40734/64A patent/GB1124285A/en not_active Expired
-
1965
- 1965-10-04 US US492930A patent/US3423408A/en not_active Expired - Lifetime
- 1965-10-05 ES ES318143A patent/ES318143A1/es not_active Expired
- 1965-10-06 DE DE1545912A patent/DE1545912C3/de not_active Expired
- 1965-10-06 CH CH1379065A patent/CH482713A/de not_active IP Right Cessation
-
1966
- 1966-01-05 FR FR44863A patent/FR4914M/fr not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| GB1124285A (en) | 1968-08-21 |
| DE1545912C3 (de) | 1979-06-21 |
| DE1545912B2 (de) | 1978-10-26 |
| CH482713A (de) | 1969-12-15 |
| FR4914M (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | 1967-03-13 |
| US3423408A (en) | 1969-01-21 |
| DE1545912A1 (de) | 1969-12-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES318143A1 (es) | Un procedimiento para la produccion de compuestos de dioxi-do de perhidro-1,2,4-tiadiazina. | |
| US3488423A (en) | Process for producing anti-inflammatory effects and compositions | |
| GB1047935A (en) | Substituted piperazines and preparation thereof | |
| ES337526A1 (es) | Un procedimiento para la manufactura de nuevas piperazinas. | |
| GB1221324A (en) | New processes for the production of benzazepine derivatives | |
| GB1294763A (en) | 3-oxo-2,3-dihydro-1,4-benzoxazine derivatives | |
| ES346521A1 (es) | Un procedimiento para la preparacion de derivados de sulfo-nilurea. | |
| GB1213172A (en) | Dibenzothiazepine derivatives and production of the same | |
| GB1384219A (en) | 2-alkylamino-dihydropyridines their production and their medicinal use | |
| GB1137796A (en) | New substituted benzo-1,4-oxazines products, their use and methods of manufacture | |
| GB871757A (en) | Basically substituted diphenyl-carbinol-esters and a process for their manufacture | |
| GB859316A (en) | Improvements in or relating to substituted 3.5-dioxotetrahydro-1.2.6-thiadiazine-1.1-dioxides | |
| GB1425578A (en) | Piperidine derivatives | |
| US3697505A (en) | Aromatic substituted amidines | |
| US2927132A (en) | 1-(4-amino-2-alkoxyphenoxy)-benzamidoalkanes | |
| GB1367305A (en) | Benzodiazocine derivatives | |
| ES321490A1 (es) | Procedimiento para la preparaciën de compuestos de dibenzociclohepteno | |
| US3439035A (en) | Aminoalkanolbenzenesulfonamides | |
| US3532741A (en) | Amino,monomethylamino and dimethylamino derivatives of decahydro-1,5,2,4 - ethanediylidenecyclopenta(cd) pentalene | |
| US3118904A (en) | Amidoximo alkyl | |
| GB1180249A (en) | Quinoxaline Compounds, their preparation and Compositions containing them | |
| GB1453910A (en) | Benzazepine derivatives | |
| GB984092A (en) | Dibenzodiazepinone compounds and methods for their production | |
| US3202670A (en) | 9-methyl-3, 4-dihydroxy-9h-pyrido-[3, 4-b] indole methochloride | |
| GB1037655A (en) | Di(aralkyl)amines |